Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Lindsey Robert Baden, M.D.

Co-Author

This page shows the publications co-authored by Lindsey Baden and Nicolas Issa.
Connection Strength

4.434
  1. Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2014 Feb; 20(2):285-7.
    View in: PubMed
    Score: 0.541
  2. Current issues in vaccines for adult patients with hematologic malignancies. J Natl Compr Canc Netw. 2012 Nov 01; 10(11):1447-54; quiz 1454.
    View in: PubMed
    Score: 0.503
  3. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011 Mar; 17(3):434-8.
    View in: PubMed
    Score: 0.436
  4. Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity. Clin Infect Dis. 2022 Aug 24; 75(1):e920-e923.
    View in: PubMed
    Score: 0.248
  5. Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome. Transplant Cell Ther. 2022 08; 28(8):508.e1-508.e8.
    View in: PubMed
    Score: 0.243
  6. Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant. Open Forum Infect Dis. 2021 Dec; 8(12):ofab504.
    View in: PubMed
    Score: 0.236
  7. Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies. Blood Adv. 2021 08 24; 5(16):3062-3065.
    View in: PubMed
    Score: 0.232
  8. Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation. Blood Adv. 2021 03 23; 5(6):1585-1593.
    View in: PubMed
    Score: 0.225
  9. Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis. Biol Blood Marrow Transplant. 2019 08; 25(8):1642-1647.
    View in: PubMed
    Score: 0.197
  10. Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib. Br J Haematol. 2019 05; 185(4):788-790.
    View in: PubMed
    Score: 0.191
  11. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018 06 12; 2(11):1272-1276.
    View in: PubMed
    Score: 0.186
  12. Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2018 07; 53(7):942-945.
    View in: PubMed
    Score: 0.181
  13. Serologic response to hepatitis B vaccination among lung transplantation candidates. Transplantation. 2014 Sep 27; 98(6):676-9.
    View in: PubMed
    Score: 0.143
  14. Pneumonia in the immunocompromised host. Curr Opin Pulm Med. 2014 May; 20(3):272-9.
    View in: PubMed
    Score: 0.139
  15. Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. JAMA Surg. 2013 May; 148(5):440-6.
    View in: PubMed
    Score: 0.130
  16. Serum galactomannan and (1->3)-ß-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia. J Clin Microbiol. 2012 Mar; 50(3):1054-6.
    View in: PubMed
    Score: 0.118
  17. Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2011 Aug; 11(4):375-7.
    View in: PubMed
    Score: 0.115
  18. US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19. Open Forum Infect Dis. 2021 Dec; 8(12):ofab563.
    View in: PubMed
    Score: 0.059
  19. Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial. Ann Intern Med. 2020 03 03; 172(5):306-316.
    View in: PubMed
    Score: 0.052
  20. Plateletpheresis-associated lymphopenia in frequent platelet donors. Blood. 2019 02 07; 133(6):605-614.
    View in: PubMed
    Score: 0.048
  21. Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation. Clin Infect Dis. 2017 Aug 01; 65(3):510-513.
    View in: PubMed
    Score: 0.044
  22. Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. PLoS One. 2015; 10(11):e0143165.
    View in: PubMed
    Score: 0.039
  23. Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease. Open Forum Infect Dis. 2014 Mar; 1(1):ofu014.
    View in: PubMed
    Score: 0.035
  24. Infections following facial composite tissue allotransplantation--single center experience and review of the literature. Am J Transplant. 2013 Mar; 13(3):770-9.
    View in: PubMed
    Score: 0.032
  25. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis. Transplantation. 2012 Aug 15; 94(3):281-6.
    View in: PubMed
    Score: 0.031
  26. Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients. Transpl Infect Dis. 2012 Aug; 14(4):427-33.
    View in: PubMed
    Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.